In the journal Clinical Cancer Research, a group of researchers, including current and past OCRF grantees Anil Sood and Gabriel Lopez-Berestein, evaluated the prognostic value of fibroblast growth factor receptor 4 (FGFR4) … Continued
A study of 425 Stage III and IV ovarian cancer patients had either primary debulking surgery or interval debulking surgery. Interval debulking surgery did not appear to increase the risk … Continued
In a study published in the American Journal of Clinical Nutrition, researchers from Curtin University in Australia found that extended breastfeeding significantly reduces the risk of ovarian cancer in women. The … Continued
A new study indicates a direct link between higher blood calcium levels and presence of ovarian cancer. Specifically, “women who were later diagnosed with ovarian cancer and women who later … Continued
A new approach to monitoring CA-125, using an algorithm that looks at its change over time, is more effective at identifying ovarian cancer earlier than using a single-threshold number.
In an analysis of more than 4,000 women with ovarian cancer, it appears that some hormonal and reproductive factors may affect tumor aggressiveness. The study showed that increased age was … Continued
A study of 149 women with platinum sensitive ovarian cancer, half treated with carboplatin and paclitaxel or gemcitabine, half with that treatment plus pertuzumab, showed that the addition of pertuzumab … Continued
OCRF receives record number of research grant applications; launches national patient support program with new educational grants New York, NY January 10, 2013 — Ovarian Cancer Research Fund (OCRF) has … Continued
OCRF has awarded nearly $6 million in grants for ovarian cancer research this year. After receiving over 170 applications – the highest number in its history, for the second year … Continued
1/09/2013 Analyzing DNA from Pap smears could help detect endometrial and ovarian cancer, a new study published Jan. 9, 2013 in Science Translational Medicine reports. OCRF Scientific Advisory Committee member (and former … Continued
1/3/2013 In the most recent edition of the Journal of Clinical Oncology, researchers in the UK published preliminary results from the United Kingdom Familial Ovarian Cancer Screen Study, a large trial testing … Continued
Lindsay Avner founded Bright Pink in 2007, shortly after she learned that she carried a mutation in the BRCA gene. Just 22 years old when she was tested, Lindsay realized … Continued
Get email updates about research news, action alerts, and ways to join the fight.
